Compare RDY & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | MKSI |
|---|---|---|
| Founded | 1984 | 1961 |
| Country | India | United States |
| Employees | N/A | 10200 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 11.0B |
| IPO Year | N/A | 1999 |
| Metric | RDY | MKSI |
|---|---|---|
| Price | $14.13 | $162.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $16.90 | ★ $149.36 |
| AVG Volume (30 Days) | 923.2K | ★ 941.7K |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | 0.50% | ★ 0.54% |
| EPS Growth | 9.95 | ★ 820.97 |
| EPS | 0.79 | ★ 4.12 |
| Revenue | ★ $3,851,623,984.00 | $3,832,000,000.00 |
| Revenue This Year | $6.16 | $10.71 |
| Revenue Next Year | $2.57 | $7.30 |
| P/E Ratio | ★ $17.94 | $39.66 |
| Revenue Growth | ★ 14.10 | 8.13 |
| 52 Week Low | $12.26 | $54.84 |
| 52 Week High | $16.17 | $164.79 |
| Indicator | RDY | MKSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 64.47 |
| Support Level | $13.64 | $134.74 |
| Resistance Level | $14.20 | $164.79 |
| Average True Range (ATR) | 0.17 | 6.77 |
| MACD | 0.05 | 1.36 |
| Stochastic Oscillator | 88.39 | 93.26 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.